Tampere offers excellent opportunities for pharmaceutical research and medical biotechnology
Tampere has very strong research capabilities for cardiovascular diseases, vaccines, celiac disease, oncology and pediatric diseases. Bioinformatics and clinical informatics provide new opportunities for health technology.
Tampere University Hospital offers excellent conditions for clinical research, which is supported by the Finnish Clinical Biobank Tampere (FCBT). FCBT is the fastest growing biobank in Finland and it is developing new methods for instance using cold chain robotics in the sample handling.
As an example, Santen, a world leading Ophthalmology company, has a major R&D unit in Tampere. In biotechnology, Tampere is particularly strong in the fields of tissue engineering and stem cell therapy. The prime example being a bone graft cultured from stem cells isolated from patient’s own tissue and grown inside his abdomen.
